环孢素从现有制剂转换为微乳剂制剂的长期结果。 - Suppr | 超能文献

Long-term results of conversion from existing to microemulsion formulation of cyclosporine.

作者信息

Neumayer H H, Färber L, Budde K, Kohnen R, Maibücher A, Schuster A, Vollmar J, Waiser J, Luft F C

机构信息

Department of Medicine-Nephrology, Humboldt University of Berlin, Germany.

出版信息

Transplant Proc. 1996 Aug;28(4):2207-13.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Long-term results of conversion from existing to microemulsion formulation of cyclosporine.环孢素从现有制剂转换为微乳剂制剂的长期结果。

Transplant Proc. 1996 Aug;28(4):2207-13.

2

Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine.与传统环孢素相比，环孢素新的口服微乳剂配方可减少环孢素谷浓度的过度波动。

Transplant Proc. 1996 Aug;28(4):2273-5.

3

Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.小儿肾、肝和心脏移植受者从环孢素转换为新山地明的情况。

Transplant Proc. 1996 Aug;28(4):2262-3.

4

Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.环孢素微乳剂（新山地明）在稳定期肾移植患者治疗24个月后的安全性和耐受性。德国新山地明研究组

Transplant Proc. 1996 Aug;28(4):2204-6.

5

Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.环孢素微乳剂在肾移植受者中的耐受性、安全性及疗效评估。

Transplant Proc. 1996 Aug;28(4):2171-3.

6

Clinical safety and tolerability of microemulsion cyclosporine in stable renal transplant patients.微乳环孢素在稳定期肾移植患者中的临床安全性和耐受性

Transplant Proc. 1996 Dec;28(6):3379.

7

Conversion from Sandimmune to Neoral and induction therapy with Neoral in pediatric renal transplant recipients.

Transplant Proc. 1996 Aug;28(4):2259-61.

8

Converting renal transplant patients maintained on Sandimmune to a new microemulsion formulation, Sandimmune Neoral.将接受环孢素（山地明）治疗的肾移植患者转换为使用新的微乳剂配方产品，即新山地明。

Transplant Proc. 1998 Nov;30(7):3521-3. doi: 10.1016/s0041-1345(98)01121-x.

9

Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.新山地明（Sandimmun Neoral）的安全性、耐受性及药代动力学：稳定期肾移植受者的转换研究

Transplant Proc. 1996 Jun;28(3):1330-2.

10

Case reports on conversion to Neoral therapy in renal transplant patients.肾移植患者转换为新山地明治疗的病例报告。

Transplant Proc. 1996 Aug;28(4):2221-2; discussion 2218.

引用本文的文献

1

Switching between cyclosporin formulations. What are the risks?转换环孢素制剂。有哪些风险？

Drug Saf. 1997 Jun;16(6):366-73. doi: 10.2165/00002018-199716060-00003.